Anzeige
Mehr »
Mittwoch, 12.08.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Seeking Alpha

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
DiOwlet GAAP EPS of -$0.01 beats by $0.08, revenue of $33.9M beats by $2.18M
DiImmunome GAAP EPS of -$0.65 misses by $0.13
DiTransAct Tech GAAP EPS of $0.00 beats by $0.01, revenue of $13.9M beats by $0.2M
DiNational CineMedia GAAP EPS of -$0.11 misses by $0.03, revenue of $58.4M misses by $1.12M
DiERock, Inc. GAAP EPS of -$0.06 beats by $0.21, revenue of $39.87M beats by $19.39M
DiSmart Sand GAAP EPS of $0.25, revenue of $115.1M
DiESS Tech GAAP EPS of -$0.46 misses by $0.02
DiEarnings Snapshot: CoreWeave Q2 revenue surge; backlog hits $104B as AI capacity expanded
DiCAVA Group GAAP EPS of $0.19 beats by $0.01, revenue of $368.44M beats by $8.35M
DiArmanino Foods of Distinction Non-GAAP EPS of $0.18, revenue of $21.7M beats by $0.7M
DiCardiff Oncology GAAP EPS of -$0.14 beats by $0.02, revenue of $0.1M beats by $0.04M
DiTherapeutics MD reports Q2 results
DiAstronics Non-GAAP EPS of $0.70 beats by $0.09, revenue of $259.96M beats by $14.66M
DiStocks to watch on Tuesday after hours: CRWV, SMCI, LITE
DiLumentum Q4 results feature 109% revenue surge with more growth ahead on AI demand
DiGrowGeneration GAAP EPS of -$0.03 in-line, revenue of $43.22M beats by $0.47M
DiEvolv Technologies Non-GAAP EPS of -$0.02 in-line, revenue of $43.8M beats by $1.99M
DiSpectral AI GAAP EPS of -$0.13 beats by $0.01
DiCAVA tops comparable sales estimates, backs its full-year guidance
DiSES AI Non-GAAP EPS of -$0.04 in-line
DiRealty Income plans $750M convertible notes offering
DiFirefly Aerospace Inc. Non-GAAP EPS of -$0.42 beats by $0.11, revenue of $117.68M beats by $29.16M
DiMineralys Therapeutics GAAP EPS of -$2.85 misses by $2.30
DiCoreWeave GAAP EPS of -$1.14 beats by $0.33, revenue of $2.58B beats by $20M
DiLENZ Therapeutics GAAP EPS of -$1.02 beats by $0.04, revenue of $5.5M beats by $3.12M